hK2 and Free PSA, a Prognostic Combination in Predicting Minimal Prostate Cancer in Screen-Detected Men within the PSA Range 4–10 ng/ml

Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer

Jonathan I. Epstein · JAMA · 1994 · 1.8K citations

Medicine, Surgery, Urology +17

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

Gerrit Draisma, Rob Boer, Suzie J. Otto et al. · JNCI Journal of the National Cancer Institute · 2003 · 1.1K citations · Full text

Medicine, Preventive Medicine, Urology +16

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

Michael W. Kattan, James A. Eastham, Thomas M. Wheeler et al. · The Journal of Urology · 2003 · 354 citations

Medicine, Oncology, Urology +17

Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

Ewout W. Steyerberg, Monique J. Roobol, Michael W. Kattan et al. · The Journal of Urology · 2006 · 308 citations

Medicine, Oncology, Urology +17

RELATIONSHIP BETWEEN SYSTEMATIC BIOPSIES AND HISTOLOGICAL FEATURES OF 222 RADICAL PROSTATECTOMY SPECIMENS: LACK OF PREDICTION OF TUMOR SIGNIFICANCE FOR MEN WITH NONPALPABLE PROSTATE CANCER

Masanori Noguchi, Thomas A. Stamey, John E. McNeal et al. · The Journal of Urology · 2001 · 235 citations

Medicine, Pathology, Urology +17